Cardiac Marker Testing Market: A Growing Sector with Potential for Change
The global cardiac marker testing market, valued at approximately £3.2 billion in 2022, is expected to grow at a compound annual growth rate (CAGR) of 9.4% between 2023 and 2030. This sector, crucial for diagnosing and assessing heart conditions like heart attacks, relies on analysing specific biomolecules in the bloodstream. These tests play a vital role in early diagnosis, risk assessment, treatment monitoring, and confirming or ruling out acute myocardial infarction.
Driving the market's expansion are several key factors:
Advances in Novel Cardiac Biomarkers: Ongoing research and the discovery of new cardiac biomarkers are fuelling market growth.
Increasing Geriatric Population and Heart Conditions: The rising number of elderly individuals and the prevalence of heart conditions are driving demand for cardiac marker testing.
Government Initiatives and Funding: Public and private initiatives focused on cardiac disease diagnosis are bolstering the market's trajectory.
The market also presents a number of opportunities:
Ongoing Research in Cardiac Biomarkers: Continued research and innovation in the field of biomarkers offer promising avenues for market expansion.
Demand for Point-of-Care Testing: The growing preference for point-of-care diagnostics, where tests are performed closer to the patient, creates new prospects for market growth.
However, the market faces challenges:
Technical Issues in Sample Collection and Storage: Challenges in sample collection and storage can hinder the efficiency of testing processes.
Assay Validation Difficulties: The validation of biomarker assays can pose difficulties, potentially slowing market growth.
Regional Analysis Highlights:
North America: Dominates the market due to the high prevalence of cardiovascular diseases and the presence of major players with established portfolios in cardiac biomarker testing.
Asia Pacific: Projected to witness rapid growth due to the increasing prevalence of cardiovascular disease, advancements in healthcare infrastructure, and the adoption of advanced immunoassay technology.
Market Segmentation:
The market can be segmented by:
Product Type: Reagents and kits, and instruments.
Biomarker Type: Troponin I and T, creatine kinase-MB, brain natriuretic peptide, myoglobin, high-sensitivity C-reactive protein, and other cardiac biomarkers.
Diseases: Myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and ischemia.
End User: Laboratory testing facilities, point-of-care testing facilities, and academic institutions.
Key Players Shaping the Market:
The major players in the cardiac marker testing market include:
F. Hoffmann-La Roche AG
Abbott Laboratories
Danaher Corporation
Siemens Healthineers AG
PerkinElmer, Inc.
BioMerieux SA
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Tosoh Corporation
Recent Market Developments:
October 2023: BD received approval from the US Food and Drug Administration (FDA) for the BD Vacutainer Troponin I Ultra test, designed for point-of-care diagnosis of acute myocardial infarction (AMI).
The comprehensive report provides a thorough analysis of trends, opportunities, and challenges impacting the cardiac marker testing market. It also includes insights into regional market dynamics, the competitive landscape, and future growth projections.
The report addresses key questions including:
What are the strengths and weaknesses of key vendors?
Who are the leading players and what are their key business plans in the near future?
What will be the market growth rate and size in the coming year?
What are the principal drivers influencing the market?
What are the key market trends impacting the growth of the global market?
Which are the trending factors influencing the market shares of leading regions across the globe?
Who are the key players and what are their strategies in the global market?
What are the market opportunities and threats faced by players in the global market?
What industry trends, drivers, and challenges are influencing its growth?
What are the key findings of the 5 forces analysis of the global industry?
This detailed report offers valuable insights for individuals, organizations, and industries seeking to understand the current state and future potential of the cardiac marker testing market.
Note: The report is available for customization to meet specific requirements, including adjusting the scope and incorporating analyses based on particular geographies or countries.
